Skip to main content
. 2020 Dec 18;15(12):e0243431. doi: 10.1371/journal.pone.0243431

Table 1. Characteristics of NHANES participants with CKD in stages G3 –G5 (study sample) and of those individuals among the study sample who were CKD aware, over time and by sex.

Total 1999–2002 2003–2006 2007–2010 2011–2014 2015–2018
Men Women Men Women Men Women Men Women Men Women
N (weighted %) N = 393 N = 442 N = 418 N = 477 N = 440 N = 532 N = 423 N = 451 N = 412 N = 423
CKD aware men / women: N (weighted %) within each variable and within each sex
Total 4411 (100.0) 70 (17.6) 40 (8.5) 53 (13.6) 40 (9.2) 67 (14.2) 57 (9.0) 68 (14.0) 68 (11.7) 103 (22.5) 92 (18.0)
CKD Stage
G3 4007 (92.7) 43 (13.2) 21 (6.0) 37 (11.0) 29 (7.1) 51 (11.1) 30 (5.3) 49 (11.3) 47 (9.1) 85 (19.8) 68 (15.7)
G4 338 (6.2) 16 (41.3) 8 (32.6) 14 (41.3) 9 (30.2) 15 (65.3) 23 (42.8) 12 (47.2) 17 (42.1) 17 (73.0) 23 (47.9)
G5 66 (1.1) 11 (97.0) 11 (72.1) 2 (93.1) 2 (81.7) 1 (49.6) 4 (90.5) 7 (83.2) 4 (69.2) 1 (33.9) 1 (25.3)
Race/Ethnicity
Caucasian 2762 (80.8) 32 (15.3) 18 (6.2) 33 (12.3) 25 (8.8) 40 (13.9) 25 (7.3) 32 (12.3) 30 (9.5) 47 (20.8) 41 (16.3)
African American 827 (9.3) 18 (28.2) 14 (21.8) 15 (30.6) 9 (13.9) 12 (14.8) 15 (15.2) 18 (28.4) 24 (26.7) 26 (30.2) 26 (27.5)
Mexican American 378 (2.8) 16 (45.2) 4 (10.3) 3 (17.2) 4 (8.7) 9 (22.0) 9 (24.2) 6 (25.0) 7 (30.1) 12 (36.0) 12 (24.7)
Other 444 (7.1) 4 (25.2) 4 (15.9) 2 (7.6) 2 (9.5) 6 (12.7) 8 (17.1) 12 (11.3) 7 (10.5) 18 (22.2) 13 (18.1)
Age Mean (SD) 73.0 (10.2)
[20,49] 142 (4.6) 9 (49.4) 2 (9.5) 3 (13.2) 1 (7.8) 1 (15.4) 5 (44.2) 4 (15.1) 8 (21.8) 9 (54.1) 5 (43.9)
[50,64] 646 (18.7) 11 (18.3) 12 (17.8) 11 (20.7) 11 (17.8) 15 (14.2) 10 (6.4) 16 (11.6) 17 (14.0) 20 (27.2) 16 (20.4)
[65,79] 1932 (44.5) 35 (16.5) 15 (6.9) 23 (14.2) 16 (9.2) 34 (16.2) 28 (9.9) 36 (17.6) 26 (10.6) 47 (19.7) 38 (14.2)
80+ 1691 (32.1) 15 (9.9) 11 (5.7) 16 (8.6) 12 (5.3) 17 (10.9) 14 (6.4) 12 (9.9) 17 (9.7) 27 (17.0) 33 (20.2)
Diabetes
No 3142 (74.7) 39 (13.6) 26 (6.9) 29 (8.4) 22 (7.7) 33 (10.2) 28 (6.1) 34 (11.1) 33 (8.0) 56 (19.1) 45 (13.1)
Yes 1269 (25.3) 31 (37.9) 14 (16.0) 24 (27.8) 18 (15.4) 34 (25.4) 29 (17.5) 34 (20.5) 35 (22.3) 47 (28.3) 47 (32.3)
Hypertension
No 868 (22.0) 7 (8.8) 5 (4.0) 6 (8.6) 4 (5.4) 10 (8.7) 3 (2.5) 3 (2.6) 9 (10.7) 13 (17.0) 7 (7.9)
Yes 3543 (78.0) 63 (20.8) 35 (9.7) 47 (15.5) 36 (10.1) 57 (16.4) 54 (10.3) 65 (17.4) 59 (12.0) 90 (24.3) 85 (20.2)
BMI Missing 191
Mean (SD) 29.4 (6.5)
<25 1048 (24.4) 8 (5.4) 3 (1.2) 7 (10.8) 9 (7.6) 14 (13.6) 12 (5.9) 13 (13.8) 6 (3.9) 20 (17.9) 11 (10.8)
Overweight (25,30] 1523 (35.8) 29 (19.9) 16 (9.8) 20 (12.3) 15 (7.8) 20 (10.4) 14 (5.1) 20 (13.5) 16 (12.1) 29 (17.3) 22 (12.7)
Obese >30 1649 (39.8) 24 (23.7) 15 (10.3) 19 (14.7) 15 (12.0) 27 (16.9) 31 (14.5) 34 (15.9) 43 (16.0) 51 (28.3) 55 (23.5)
Smoker Missing 2227
No 1801 (82.2) 32 (14.3) 15 (12.8) 26 (13.8) 12 (8.3) 47 (17.6) 18 (11.2) 36 (17.2) 23 (10.6) 57 (25.3) 34 (18.4)
Yes 383 (17.8) 11 (36.3) 4 (9.3) 8 (29.7) 3 (9.0) 8 (26.0) 6 (6.6) 4 (10.9) 6 (19.5) 10 (17.1) 6 (21.5)
Income Missing 169
>20.000 2920 (75.2) 42 (16.8) 25 (12.0) 36 (13.1) 21 (8.7) 48 (13.2) 33 (8.0) 57 (14.5) 43 (11.7) 68 (20.4) 56 (15.5)
<20.000 1322 (24.8) 23 (21.9) 11 (5.5) 17 (17.8) 16 (10.1) 19 (20.4) 23 (11.8) 11 (12.3) 24 (11.6) 28 (34.3) 35 (27.0)
Education
High School or higher 2908 (74.6) 35 (18.2) 23 (8.2) 36 (12.3) 25 (10.1) 32 (10.5) 34 (8.4) 46 (13.1) 48 (11.8) 77 (23.1) 65 (16.3)
less than High School 1503 (25.4) 35 (16.5) 17 (9.0) 17 (17.4) 15 (7.4) 35 (25.2) 23 (10.4) 22 (17.1) 20 (11.5) 26 (19.9) 27 (27.4)
Health Insurance
No 201 (4.3) 4 (32.3) NA (0.0) 2 (17.3) 3 (15.1) 2 (6.7) 4 (15.9) 7 (28.1) 5 (16.0) 6 (42.2) 4 (17.4)
Yes 4210 (95.7) 66 (17.0) 40 (9.1) 51 (13.5) 37 (9.0) 65 (14.5) 53 (8.6) 61 (13.4) 63 (11.5) 97 (21.1) 88 (18.0)
Healthcare Visits Missing 14
0 140 (2.9) 1 (8.2) 1 (4.1) 2 (7.7) NA (0.0) NA (0.0) NA (0.0) 2 (10.1) NA (0.0) 2 (31.9) 1 (5.9)
1–3 1420 (33.5) 11 (7.3) 10 (7.0) 11 (6.8) 9 (8.1) 13 (9.4) 9 (6.7) 13 (9.0) 11 (5.2) 28 (20.3) 21 (9.6)
4–12 1713 (39.2) 31 (21.9) 15 (10.9) 14 (11.6) 16 (7.4) 29 (15.5) 17 (5.6) 22 (12.0) 35 (14.8) 42 (20.1) 44 (24.9)
>12 1124 (24.4) 27 (28.9) 14 (7.8) 26 (24.0) 15 (15.7) 25 (19.9) 31 (17.8) 31 (24.7) 22 (15.3) 31 (28.9) 24 (19.8)
Overall CKD Awareness (weighted %) 11.2% 10.7% 10.8% 12.8% 19.8%

Entire Column 1 (left) and row 3: NHANES participants with CKD in stages G3 –G5. Columns 2–11 (right), Rows 5–47: CKD aware individuals among the study sample participants (N’s and survey-weighted percentages), by 4-year study period and sex. Row 48: Overall CKD awareness over time.